0001019056-21-000147.txt : 20210217
0001019056-21-000147.hdr.sgml : 20210217
20210217210329
ACCESSION NUMBER: 0001019056-21-000147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210129
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Marvin L
CENTRAL INDEX KEY: 0001493324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 21647353
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
white.xml
X0306
4
2021-01-29
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001493324
White Marvin L
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
1
0
0
President and CEO
Stock Option (right to buy)
33.50
2021-01-29
4
A
0
43125
0
A
2031-01-29
Common Stock
43125
43125
D
Restricted Stock Unit
2021-01-29
4
A
0
14375
0
A
Common Stock
14375
14375
D
The option vests in three approximately equal annual installments beginning on January 29, 2022.
Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.
The RSU vests in three approximately equal annual installments beginning on January 29, 2022.
/s/ Carl A. Valenstein, attorney-in-fact
2021-02-17